JP2024504902A5 - - Google Patents

Info

Publication number
JP2024504902A5
JP2024504902A5 JP2023532743A JP2023532743A JP2024504902A5 JP 2024504902 A5 JP2024504902 A5 JP 2024504902A5 JP 2023532743 A JP2023532743 A JP 2023532743A JP 2023532743 A JP2023532743 A JP 2023532743A JP 2024504902 A5 JP2024504902 A5 JP 2024504902A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
weight
amount
contained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023532743A
Other languages
English (en)
Japanese (ja)
Other versions
JP7720911B2 (ja
JP2024504902A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/MX2020/050050 external-priority patent/WO2022119430A1/es
Publication of JP2024504902A publication Critical patent/JP2024504902A/ja
Publication of JP2024504902A5 publication Critical patent/JP2024504902A5/ja
Application granted granted Critical
Publication of JP7720911B2 publication Critical patent/JP7720911B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023532743A 2020-12-04 2020-12-04 痛みに対するオピオイド鎮痛薬と抗てんかん薬のコーティングされた安定な固体医薬組成物 Active JP7720911B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2020/050050 WO2022119430A1 (es) 2020-12-04 2020-12-04 Composición farmacéutica sólida recubierta y estable de un analgésico opioide y un antiepiléptico para el dolor

Publications (3)

Publication Number Publication Date
JP2024504902A JP2024504902A (ja) 2024-02-02
JP2024504902A5 true JP2024504902A5 (enExample) 2025-05-13
JP7720911B2 JP7720911B2 (ja) 2025-08-08

Family

ID=81853431

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023532743A Active JP7720911B2 (ja) 2020-12-04 2020-12-04 痛みに対するオピオイド鎮痛薬と抗てんかん薬のコーティングされた安定な固体医薬組成物

Country Status (10)

Country Link
US (1) US20240000727A1 (enExample)
EP (1) EP4230199A4 (enExample)
JP (1) JP7720911B2 (enExample)
KR (1) KR20230117591A (enExample)
CA (1) CA3199166A1 (enExample)
CO (1) CO2023008896A2 (enExample)
DO (1) DOP2023000095A (enExample)
MX (1) MX2022015331A (enExample)
PE (2) PE20252750A1 (enExample)
WO (1) WO2022119430A1 (enExample)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637767A (en) 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US20020187996A1 (en) 2001-05-14 2002-12-12 Dewey Stephen L. Prevention of addiction in pain management
WO2005041925A2 (en) 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption
MX2007008833A (es) 2005-01-21 2008-03-25 Pharmanova Inc Formulaciones farmaceuticas y metodos de uso.
JP2007018123A (ja) 2005-07-06 2007-01-25 Kyocera Mita Corp 画像処理装置、及び画像処理システム
MXPA05011735A (es) 2005-11-01 2007-04-30 Leopoldo Espinosa Abdala Composiciones farmaceuticas que comprenden combinaciones de analgesicos y anticonvulsivantes para el tratamiento del dolor agudo y cronico.
DE102007019071A1 (de) 2007-04-23 2008-10-30 Ratiopharm Gmbh Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
WO2009080365A1 (en) 2007-12-21 2009-07-02 Synthon B.V. Pregabalin salts
TR200909613A1 (tr) 2009-12-22 2011-07-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Pregabalinin farmasötik bileşimleri.
EP2590636A1 (en) 2010-07-06 2013-05-15 Grünenthal GmbH Novel gastro- retentive dosage forms comprising a gaba analog and an opioid
WO2012048294A2 (en) 2010-10-07 2012-04-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
US20150313892A1 (en) 2014-02-07 2015-11-05 Trinity Laboratories, Inc. Pharmaceutical compositions for treating pain associated with dysmenorrhea
EP3484456A4 (en) 2016-07-17 2020-03-18 Mapi Pharma Limited EXTENDED-RELEASE GALENIC FORMS OF PREGABALINE
MX2017016720A (es) 2017-12-19 2019-06-20 Monte Verde S A Composición farmacéutica que contiene un analgésico de tipo opioide en combinación con un análogo del ácido g-aminobutírico (gaba).
KR20190075718A (ko) * 2017-12-21 2019-07-01 주식회사 네비팜 용출율이 개선된 트라마돌 또는 이의 약학적으로 허용가능한 염 및 프레가발린 또는 이의 약학적으로 허용가능한 염을 포함하는 다층 제제
WO2020044070A1 (es) 2018-08-30 2020-03-05 Grünenthal GmbH Combinación farmacéutica sinérgica que comprende tramadol clorhidrato y pregabalina, y su uso para el tratamiento del dolor neuropático

Similar Documents

Publication Publication Date Title
JP2011500583A5 (enExample)
JP2021512117A5 (enExample)
JP2021001196A5 (enExample)
JP6814886B2 (ja) ベンゾイミダゾール誘導体を含む新規な製剤
JP2023536667A5 (enExample)
EP3326619B1 (en) Solid oral pharmaceutical compositions comprising tenofovir and emtricitabine
RU2003126177A (ru) Способ приготовления негигроскопичной композиции вальпроата натрия
US9132132B2 (en) Pharmaceutical compositions of linezolid
JP2018530566A5 (enExample)
US11576917B2 (en) Pharmaceutical compositions comprising Ibrutinib
EP3813822A2 (en) Solid oral pharmaceutical compositions comprising teriflunomide
JP2023551712A5 (enExample)
EP2801352B1 (en) Orally disintegrating formulations of Lacosamid
JP2017203013A (ja) エゼチミブ含有医薬組成物及びその製造方法、エゼチミブ含有医薬組成物の硬度低下抑制剤及び硬度低下抑制方法、並びにエゼチミブ含有医薬組成物の吸湿抑制剤及び吸湿抑制方法
JP2018145095A (ja) エルロチニブ塩酸塩含有医薬組成物
WO2011093828A2 (en) Solid dosage forms comprising cefprozil
JP7226697B2 (ja) ブロナンセリン含有錠剤
EP2959889A1 (en) Orally disintegrating formulations of loxoprofen
US20150328215A1 (en) Stable amorphous raltegravir potassium premix and process for the preparation thereof
WO2015069203A1 (en) Capsule comprising rupatadine fumarate and montelukast sodium
JP2020090464A5 (enExample)
US20130143857A1 (en) Pharmaceutical compositions of cefditoren pivoxil
JP6379884B2 (ja) 口腔内崩壊錠、及び口腔内崩壊錠の製造方法
AU2007101090A4 (en) Process for the preparation of a solid pharmaceutical dosage form
JP7423297B2 (ja) 口腔内崩壊錠およびその製造方法